By Kibkabe Araya
Daily Journal Staff Writer
Daily Journal Staff Writer
Orexigen Therapeutics Inc., a La Jolla obesity-focused pharmaceutical company, named Thomas P. Lynch general counsel, executive vice president and secretary late last week.
Lynch, who worked at Novartis AG in Switzerland and for its subsidiary Alcon Laboratories Inc. near Dallas, inherits the legal department from acting general counsel Christopher D. Hazuka.
Las...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In




